DPP-4 inhibitor and alpha-glucosidase inhibitor equally improve endothelial function in patients with type 2 diabetes: EDGE study

Dipeptidyl peptidase-4 inhibitors and GLP-1 reduce myocardial infarct size in a glucose-dependent manner

(2013) Derek J Hausenloy et al.   Cardiovascular Diabetology

Cardiovascular safety of sitagliptin in patients with type 2 diabetes mellitus: a pooled analysis

(2013) Samuel S Engel et al.   Cardiovascular Diabetology

Alogliptin ameliorates postprandial lipemia and postprandial endothelial dysfunction in non- diabetic subjects: a preliminary report

(2013) Yoko Noda et al.   Cardiovascular Diabetology

Advanced glycation end products evoke endothelial cell damage by stimulating soluble dipeptidyl peptidase-4 production and its interaction with mannose 6-phosphate/insulin-like growth factor II receptor

(2013) Yuji Ishibashi et al.   Cardiovascular Diabetology

Effects of sitagliptin beyond glycemic control: focus on quality of life

(2013) Yoshiko Sakamoto et al.   Cardiovascular Diabetology

Dipeptidyl Peptidase-4 Inhibitor, Sitagliptin, Improves Endothelial Dysfunction in Association With Its Anti-Inflammatory Effects in Patients With Coronary Artery Disease and Uncontrolled Diabetes

(2013) Junichi Matsubara et al.   CIRCULATION JOURNAL

Comparison of Glycemic Variability in Patients with Type 2 Diabetes Given Sitagliptin or Voglibose: A Continuous Glucose Monitoring–Based Pilot Study

(2013) Chiaki Seo et al.   Diabetes Technology & Therapeutics

Variability and reproducibility of flow-mediated dilatation in a multicentre clinical trial

(2013) Marietta Charakida et al.   EUROPEAN HEART JOURNAL

Relationship between flow-mediated vasodilation and cardiovascular risk factors in a large community-based study

(2013) Tatsuya Maruhashi et al.   HEART

Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes

(2013) William B. White et al.   NEW ENGLAND JOURNAL OF MEDICINE

Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus

(2013) Benjamin M. Scirica et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cardiovascular Effects of Dipeptidyl Peptidase-4 Inhibitors: From Risk Factors to Clinical Outcomes

(2013) André J. Scheen   POSTGRADUATE MEDICINE

Dipeptidyl Peptidase‐4 Inhibitors Attenuate Endothelial Function as Evaluated by Flow‐Mediated Vasodilatation in Type 2 Diabetic Patients

(2013) Makoto Ayaori et al.   Journal of the American Heart Association

The glucagon-like peptide 1 analog liraglutide reduces TNF-α-induced oxidative stress and inflammation in endothelial cells

(2012) Aya Shiraki et al.   ATHEROSCLEROSIS

Dipeptidyl Peptidase 4 Inhibitor Sitagliptin Protects Endothelial Function in Hypertension Through a Glucagon–Like Peptide 1–Dependent Mechanism

(2012) Limei Liu et al.   HYPERTENSION

The Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Improves Vascular Endothelial Function in Type 2 Diabetes

(2012) Yoshiaki Kubota et al.   JOURNAL OF KOREAN MEDICAL SCIENCE

Impact of Hypertriglyceridemia on Endothelial Dysfunction During Statin ± Ezetimibe Therapy in Patients With Coronary Heart Disease

(2011) Kei Yunoki et al.   AMERICAN JOURNAL OF CARDIOLOGY

Effect of 3-Month Repeated Administration of Miglitol on Vascular Endothelial Function in Patients With Diabetes Mellitus and Coronary Artery Disease

(2011) Takuo Emoto et al.   AMERICAN JOURNAL OF CARDIOLOGY

Ezetimibe improves postprandial hyperlipemia and its induced endothelial dysfunction

(2011) Kei Yunoki et al.   ATHEROSCLEROSIS

Postprandial endothelial dysfunction in subjects with new-onset type 2 diabetes: an acarbose and nateglinide comparative study

(2010) Toru Kato et al.   Cardiovascular Diabetology

Single Administration of α-Glucosidase Inhibitors on Endothelial Function and Incretin Secretion in Diabetic Patients With Coronary Artery Disease

(2010) Makoto Hiki et al.   CIRCULATION JOURNAL

The Oral Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Increases Circulating Endothelial Progenitor Cells in Patients With Type 2 Diabetes: Possible role of stromal-derived factor-1 

(2010) G. P. Fadini et al.   DIABETES CARE

Efficacy and safety of sitagliptin monotherapy compared with voglibose in Japanese patients with type 2 diabetes: a randomized, double-blind trial

(2010) Y. Iwamoto et al.   DIABETES OBESITY & METABOLISM

Glucagon-like peptide-1-based therapies and cardiovascular disease: looking beyond glycaemic control

(2010) P. Anagnostis et al.   DIABETES OBESITY & METABOLISM

Dose-ranging efficacy of sitagliptin, a dipeptidyl peptidase-4 inhibitor, in Japanese patients with type 2 diabetes mellitus

(2010) Yasuhiko Iwamoto et al.   ENDOCRINE JOURNAL

Number of circulating endothelial progenitor cells as a marker of vascular endothelial function for type 2 diabetes

(2010) Yun-fei Liao et al.   VASCULAR MEDICINE

Revised Equations for Estimated GFR From Serum Creatinine in Japan

(2009) Seiichi Matsuo et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Effect of Acarbose on Vascular Disease in Patients with Abnormal Glucose Tolerance

(2008) Markolf Hanefeld et al.   CARDIOVASCULAR DRUGS AND THERAPY

Effects of the Alpha Glucosidase Inhibitor Acarbose on Endothelial Function after a Mixed Meal in Newly Diagnosed Type 2 Diabetes

(2008) F. Pistrosch et al.   HORMONE AND METABOLIC RESEARCH